Allstate Corporation’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,030
Closed -$499K 623
2022
Q3
$499K Sell
2,030
-372
-15% -$100K 0.01% 492
2022
Q2
$595K Buy
2,402
+1,183
+97% +$319K 0.02% 463
2022
Q1
$404K Buy
1,219
+24
+2% +$7.39K 0.01% 534
2021
Q4
$429K Hold
1,195
0.01% 694
2021
Q3
$389K Sell
1,195
-194
-14% -$65.7K 0.02% 562
2021
Q2
$434K Sell
1,389
-228
-14% -$69.9K 0.01% 558
2021
Q1
$515K Buy
1,617
+248
+18% +$79.4K 0.02% 532
2020
Q4
$444K Buy
1,369
+43
+3% +$11.9K 0.01% 543
2020
Q3
$367K Sell
1,326
-265
-17% -$76.3K 0.01% 518
2020
Q2
$384K Buy
+1,591
New +$319K 0.01% 516
2019
Q3
Sell
-4,056
Closed -$1.06M 544
2019
Q2
$1.06M Buy
+4,056
New +$1.08M 0.02% 383

Other funds holding ABMD

Allstate Corporation's ABMD Position: Q4 2022 in Review

Allstate Corporation sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,030 shares — an estimated $499K sold.

Allstate Corporation first reported a position in ABMD in Q2 2019 and held it in 11 quarters. The position peaked at $1.06M in Q2 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Allstate Corporation reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Allstate Corporation sold 2,030 Abiomed Inc shares in Q4 2022, an estimated $499K.
  • Allstate Corporation first reported a position in Abiomed Inc in Q2 2019 and held it in 11 quarters.
  • Allstate Corporation's Abiomed Inc position peaked at $1.06M in Q2 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Allstate Corporation's 13F filing for Q4 2022, filed 14 Feb 2023.